"Iron sharpens iron, so one man sharpens another." Proverbs 27:17

Patient-Specific Cancer Testing

CorrectChemo® is a clinical pathology lab that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. CorrectChemo® uses a patented technology called the Microculture Kinetic (MiCK) assay®, which measures apoptosis (cell death) induced in a specific patient’s cancer cells by chemotherapy.

CorrectChemo's® assay is the ONLY test on the market that evaluates the chemotherapeutic drug effect for a specific patient and can tell which chemotherapy drugs are most effective. The assay has been used successfully in more than 50 different tumor types
Detailed Information
Learn about the benefits of CorrectChemo's® MiCK assay® from CorrectChemo's® Chief Medical Officer, Dr. Cary Presant.